Micropoint Bioscience, Inc.
- Home
- Companies
- Micropoint Bioscience, Inc.
- Products
- Micropoint mLabs - Model SARS-CoV-2 - ...
Micropoint mLabs - Model SARS-CoV-2 -IgG/IgM Assay
The mLabs SARS-CoV-2 IgG and IgM assay is a fluorescent microparticle immunoassay intended for the qualitative detection of the total IgC and IgM antibodies to SARS-CoV-2 in human whole blood, and plasma.
Most popular related searches
fluorescence immunoassay
microfluidic technology
PCR test
PCR testing
assay
immunoassay
sample collection
microfluidic
All samples were collected from individuals who were confirmed as positive or negative for the SARS-CoV-2 virus by various (FDA-authorized) PCR tests.
Features:
-
Easy-to-use touchscreen operation
-
Fast: qualitative results in 4-8 minutes
-
Stable: the signal is stable after testing and remains constant for at least 30 minutes
-
Patented microfluidic technology enables highly precise and reliable qualitative fluorescence immunoassay testing